iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.
600 Madison Avenue
New York, NY 10022
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)